en
Resources center summary
Proton Therapy Publication

August 2021
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma
Proton Therapy Publication

July 2021
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
Proton Therapy Publication

June 2021
The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma.
Proton Therapy Publication

June 20221
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
Proton Therapy Publication

May 2021
Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma
Proton Therapy Publication

April 2021
Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma
Proton Therapy Publication

January 2021
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory lymphoma: A PTCOG and PCG Collaboration.
Proton Therapy Publication

October 2019
Proton Therapy For Lymphomas: Current State Of The Art
Proton Therapy Publication

October 2019
Proton Therapy For Lymphomas: Current State Of The Art
Proton Therapy Publication

January 2019
Clinical IMPT for Hodgkin lymphoma: which patients benefit the most?
Proton Therapy Publication

August 2018
Proton theraphy for adults with mediastinal lymphomas: The international lymphoma radiation oncology group (ILROG) guidelines.
Proton Therapy Publication

September 2017
Evidence-based Review on the Use of PT in Lymphoma from the PTCOG Lymphoma Subcommittee.
Proton Therapy Publication

August 2016
2-year relapse-free survival of 85% with no grade 3 toxicity